What decision was AI permitted to make or shape?
Was AI informing, recommending, ranking, initiating, approving, denying, or executing?
Prior authorization decision control
Why was AI allowed to make or materially shape this coverage decision?
A prior authorization decision cannot be defended by pointing only to a model score or a reviewer signature. The organization must reconstruct the evidence, the role AI played, the authority that applied, and why approval, denial, evidence request, or escalation was permitted.
Prepare the case. Preserve the authority.Reduce evidence friction while making the basis for review visible.
The defensibility test
Five questions must be answered as one chain of evidence.
The first question is why AI was allowed to make or materially shape the decision. The remaining questions establish whether that authority was justified.
Was the evidence sufficient for this case?
What was present, missing, current, relevant, and available to the reviewer?
Was the case within demonstrated competence?
Did the case resemble conditions under which the system had been evaluated, or was it novel?
Was human review meaningful?
Could the reviewer see the evidence, disagree, change the action, and own the consequence?
Why did this action proceed?
Why was approval, denial, evidence request, escalation, or hold justified at that moment?
A coverage decision in motion
High confidence does not authorize the workflow to act.
The case can change after submission. Evidence can conflict. A recommendation can remain confident even when a prerequisite is missing. Decision control changes the permitted action when the case state changes.
CMS-0057-F
CMS-0057-F shapes the operating environment. Defensibility remains a decision-level question.
The defensibility question is separate: can the organization reconstruct why this particular determination was allowed to proceed?
Buyer questions
Questions behind a defensible coverage determination.
The organization must be able to reconstruct evidence, authority, review, and action.
Why is AI-influenced prior authorization a defensibility problem?
The organization may need to explain why AI was allowed to influence a particular review, recommendation, approval, or denial. That requires visibility into individualized review, the evidence available, the authority exercised, and whether the decision state can be reconstructed later.
How does CMS-0057-F appear in GNS-AI’s prior authorization work?
CMS-0057-F is part of the operating context for prior authorization. GNS-AI focuses on a separate decision-level issue: whether an organization can reconstruct the evidence, individualized review, AI influence, and authority behind a particular determination. Responsible legal and compliance teams determine how the rule applies.
Does GNS-AI automate clinical judgment?
The objective is not to hide or replace qualified judgment. GNS-AI helps the workflow move evidence-supported cases, identify what remains unresolved, make authority explicit, and route cases to the right human when the decision should not proceed automatically.
Start with the current decision
Bring one prior authorization workflow.
Bring the prior-authorization workflow, current bottleneck, and decision that needs to improve.
Low-friction entry points: executive briefing, applied workshop, AI pilot and commercial assurance, workflow blueprint, production validation, or DCP shadow mode.